Stanford School of Medicine
Obstetrics & Gynecology (ObGyn)–

Ruth Lathi, MD

Phone:(650) 498-7911
Profile: http://med.stanford.edu/profiles/Ruth_Lathi/

Alternate Contact:
Name: Tracy Lindsay
Title: Administrative Assistant
Email: tracyl@stanford.edu
Phone: 650-498-7408

Academic Appointments
Appointment
Organization
Assistant Professor - Med Center Line
Obstetrics & Gynecology
Graduate & Fellowship Program Affiliations
Obstetrics and Gynecology ;
 
Honors & Awards
Title
Organization
Date(s)
CREOG - Faculty Teaching Award
Stanford University Medical Center, Department of Obstetrics and Gynecology
2006
Administrative Appointments
Title
Organization
Start Year
End Year
Director, Recurrent Pregnancy Loss Program
Reproductive Endocrinology & Infertilty Division, Stanford University
2007
-
Associate Director of the REI fellowship
Stanford University
2004
-
Professional Education
Degree
Awarding Institution
Field of Study
Year of Graduation
Board Certified
American Board of OB/GYN
Reproductive Endocrinology and Infertility
2006
Board Certified
American Board of OB/GYN
Obstetrics and Gynecology
2005
MD
UC-San Francisco
Medicine
1996
BS
M.I.T.
Biology
1992
Web Site Links
Research/Lab website:   REI CLINIC
Research Interests

Pregnancies after infertility: prospectively collecting serum and consent for outcomes research in all women with history of infertility or recurrent miscarriage. Planned projects include evaluation of testosterone levels in relationship to fertility treatments, prospective study on pregnancy outcomes of women with PCOS compared to other women undergoing fertility treatments, miscarriage rates with different diagnoses and treatments.

Karyotypes of miscarriages: collecting karyotype information, ultrasound findings and clinical characteristics on patients miscarrying undergoing D&Cs. Over 350 karyotypes already entered. Objective: to evaluate subsequent pregnancy outcomes and utility of workup for recurrent pregnancy loss in setting of normal and abnormal karyotypes.

Unexplained recurrent pregnancy loss and immune changes. Objective: analyzing peripheral blood and RNA by micro array analysis in women with and without unexplained recurrent pregnancy loss during the luteal phase of the menstrual and early pregnancy.

Publications
  • Moayeri SE, Lee HC, Lathi RB, Westphal LM, Milki AA, Garber AM "Laparoscopy in women with unexplained infertility: a cost-effectiveness analysis." Fertil Steril 2008; More »
  • McLaren JF, Burney RO, Milki AA, Westphal LM, Dahan MH, Lathi RB "Effect of methotrexate exposure on subsequent fertility in women undergoing controlled ovarian stimulation." Fertil Steril 2008; More »
  • Massie JA, Burney RO, Milki AA, Westphal LM, Lathi RB "Basal follicle-stimulating hormone as a predictor of fetal aneuploidy." Fertil Steril 2008; More »
  • Davis LB, Lathi RB, Milki AA, Dahan MH "Transvaginal ligation of the cervical branches of the uterine artery and injection of vasopressin in a cervical pregnancy as an initial step to controlling hemorrhage: a case report." J Reprod Med 2008; 53: 5: 365-8 More »
  • Lathi RB, Westphal LM, Milki AA "Benefits of PGD in patients with recurrent miscarriages?" Fertil Steril 2008; More »
29 publications:   view full list

Institution Links:

Footer Links: